The Cost of Obesity
- 1 January 1994
- journal article
- Published by Springer Nature in PharmacoEconomics
- Vol. 5 (Supplement) , 34-37
- https://doi.org/10.2165/00019053-199400051-00007
Abstract
Obesity is associated with an increased risk of many major chronic diseases. We estimated the economic costs of obesity-associated non-insulin-dependent diabetes mellitus, cardiovascular disease, gallbladder disease, cancer, and musculoskeletal disorders in 1990 US dollars, using a prevalence-based approach to cost-of-illness. In addition to direct costs, indirect costs were also estimated. The indirect cost of morbidity was estimated by calculating the costs associated with work days lost, and mortality costs were estimated on the basis of lifetime earnings lost. In 1990, the direct cost of obesity-associated disease in the US was $US45.8 billion, and the indirect cost of obesity was estimated to be $US23.0 billion. Therefore the total economic cost of obesity was estimated to be $US68.8 billion in 1990.Keywords
This publication has 12 references indexed in Scilit:
- Obesity in EuropePharmacoEconomics, 1994
- Risk of symptomatic gallstones in women with severe obesityThe American Journal of Clinical Nutrition, 1992
- Economic costs of obesityThe American Journal of Clinical Nutrition, 1992
- WEIGHT AS A RISK FACTOR FOR CLINICAL DIABETES IN WOMENAmerican Journal of Epidemiology, 1990
- A Prospective Study of Obesity and Risk of Coronary Heart Disease in WomenNew England Journal of Medicine, 1990
- The economic costs of non-insulin-dependent diabetes mellitusPublished by American Medical Association (AMA) ,1989
- The prevalence of overweight and obesity in Britain, Canada, and United States.American Journal of Public Health, 1987
- The economic costs of illness: A replication and update1985
- Health care expenditures for major diseases in 1980.1984
- IMPACT OF RECENT CHANGES IN DIAGNOSTIC CRITERIA ON THE APPARENT NATURAL HISTORY OF DIABETES MELLITUSAmerican Journal of Epidemiology, 1983